Staff Clinician
National Heart Lung and Blood Institute, National Institutes of Health
Washington, District of Columbia, United States
Dr. Emily Limerick is an assistant research physician in NHLBI working in the Laboratory of Early Sickle Mortality Prevention. She completed her pediatric hematology/oncology fellowship in the combined Johns Hopkins- NIH training program. Dr. Limerick's research focuses on haploidentical stem cell transplantation for sickle cell disease as well as biomarkers of organ function in sickle cell disease, specifically sickle nephropathy with a burgeoning interest in sickle cardiomyopathy. She has authored multiple publications exploring the effects of transplant on cardiac function in patients with sickle cell disease. She is the principal investigator of a study exploring markers of sickle nephropathy which has completed accrual with data analysis ongoing. Dr. Limerick is a past participant in the American Society of Hematology’s Clinical Research Training Institute. She is currently pursuing her Masters in Clinical Research through the combined Duke-NIH Clinical Research Training Program; her thesis work explores renal function in patients with sickle cell disease after stem cell transplantation.
Disclosure information not submitted.
Educational Session Focused on Survivorship: Post-Transplant and Post-Gene Therapy
Saturday, June 8, 2024
10:00 AM – 12:00 PM ET
Saturday, June 8, 2024
10:00 AM – 10:15 AM ET